AnGes : filed for approval of its HGF gene therapy product Collategene® for the first time since the introduction of the conditional/time-limited authorization system for regenerative medicine products
May 31, 2023 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO ... | May 31, 2023
Source: marketscreener.com